ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 365 participants.
Also called NCT01694563
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 365 participants
- Sponsor
- Registry
-
NCT01694563
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01694563. Allocation not applicable; no masking; primary purpose treatment. Start 2012-09 (actual); primary completion 2017-10-23 (actual). Results posted on 2019-09-13.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation
- Acronym
- ABLATE-PAS
- Condition
- Persistent Atrial Fibrillation
- Condition
- Longstanding Persistent Atrial Fibrillation
- Intervention (Device)
- Synergy Ablation System
- Lead sponsor
- AtriCure, Inc.
Record details
- Record id
cardio:ct-nct01694563- Content hash
ef49d896fa4e7d3c99c8d6142bd61374de4268c010e712a15a38c9572150671d